Melanotan 2 (MT-II) 10MG

Melanotan 2 (MT-II), also known as α-MSH (alpha-melanocyte-stimulating hormone) analog, is a synthetic peptide derived from the melanocortin system, originally developed for its potential effects on skin pigmentation and UV protection in laboratory settings. This research-use-only compound is typically employed in controlled scientific investigations to explore its biological mechanisms without any claims of therapeutic or cosmetic utility in humans or animals.

Research Context

MT-II has been studied extensively in preclinical models as part of research examining the role of melanocortin peptides in skin pigmentation, tanning responses, and potential protective mechanisms against UV-induced damage. Early findings in animal studies suggested that MT-II could induce localized skin darkening through activation of melanocortin-1 receptors (MC1R), which are key regulators of melanin production. This work remains confined to research environments due to ethical, regulatory, and safety considerations applicable to human trials.

Research Overview

The primary focus of MT-II research has revolved around its ability to stimulate melanogenesis, particularly in the context of controlled UV exposure studies. While some initial investigations suggested potential UV-protective effects in animal models, subsequent research clarified that the peptide’s role is highly context-dependent and varies by dosage, delivery method, and experimental conditions. Due to its potential for unintended systemic effects, MT-II is not used in human or veterinary applications outside of highly regulated and supervised studies.

Key Research Focus Areas

• Melanocortin Receptor Signaling: Investigation into how MT-II engages MC1R pathways to modulate melanin synthesis and skin pigmentation in laboratory animals.
• UV Protection Mechanisms: Preclinical studies assessing whether MT-II-induced pigmentation confers any measurable protection against UV-induced oxidative stress or cellular damage.
• Pharmacokinetics in Non-Human Models: Characterization of peptide absorption, distribution, and metabolic clearance in rodents, primates, and other research organisms.
• Toxicological Profile: Evaluation of acute and chronic safety parameters, including potential adverse effects such as skin irritation, systemic inflammation, or receptor desensitization.
• Comparative Peptide Dynamics: Comparative analyses of MT-II versus other melanocortin analogs (e.g., Melanotan I) to elucidate differences in efficacy, specificity, and off-target effects.

Important Notice

This product is intended solely for research purposes in accredited academic, industrial, or government laboratories. It is not intended for use in humans, animals, or any commercial applications. Distribution or possession without proper authorization is illegal in many jurisdictions. Unauthorized use may pose severe health risks, including unintended physiological responses, allergic reactions, or regulatory violations.

Compliance Statement

For research use only. Not for human or animal consumption. Always adhere to the guidelines of your institution and regulatory authorities regarding handling, storage, and disposal of research chemicals.